tiprankstipranks
Sagimet Biosciences, Inc. Class A (SGMT)
NASDAQ:SGMT
US Market

Sagimet Biosciences, Inc. Class A (SGMT) Financial Statements

152 Followers

Sagimet Biosciences, Inc. Class A Financial Overview

Sagimet Biosciences, Inc. Class A's market cap is currently ―. The company's EPS TTM is $-1.278; its P/E ratio is -4.24; Sagimet Biosciences, Inc. Class A is scheduled to report earnings on March 25, 2024, and the estimated EPS forecast is $-0.58. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23
Income Statement-
Total Revenue$ 2.00M-
Gross Profit$ 2.00M-
EBIT-$ -6.79M
EBITDA--
Net Income Common Stockholders$ -6.35M$ -6.79M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 101.84M$ 18.51M
Total Assets$ 102.92M$ 21.50M
Total Debt$ 103.00K$ 140.00K
Net Debt$ -101.74M$ -18.37M
Total Liabilities$ 5.05M$ 219.91M
Stockholders Equity$ 97.88M$ -198.41M
Cash Flow-
Free Cash Flow$ -16.68M-
Operating Cash Flow$ -16.68M-
Investing Cash Flow$ 32.20M-
Financing Cash Flow$ 86.17M-
Currency in USD

Sagimet Biosciences, Inc. Class A Earnings and Revenue History

Sagimet Biosciences, Inc. Class A Debt to Assets

Sagimet Biosciences, Inc. Class A Cash Flow

Sagimet Biosciences, Inc. Class A Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis